6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Interstitial lung diseases induced or exacerbated by DMARDS and biologic agents in rheumatoid arthritis: a systematic literature review.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          To review published cases of induced or exacerbated interstitial lung disease (ILD) in rheumatoid arthritis (RA) associated with non-biologic disease-modifying antirheumatic drugs (nbDMARDs) and biologics and to discuss clinical implications in daily practice.

          Related collections

          Author and article information

          Journal
          Semin. Arthritis Rheum.
          Seminars in arthritis and rheumatism
          1532-866X
          0049-0172
          Apr 2014
          : 43
          : 5
          Affiliations
          [1 ] Osteoarthritis Research Unit, University of Montreal Hospital Research Center (CRCHUM), Notre-Dame Hospital, Montreal, Quebec, Canada.
          [2 ] Department of Medicine, Rheumatic Disease Unit, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, Quebec, Canada; Institut de rhumatologie de Montréal, 1551 Ontario St East, Montreal, Quebec, Canada H2L 1S6. Electronic address: boulos.haraoui@ssss.gouv.qc.ca.
          Article
          S0049-0172(13)00201-1
          10.1016/j.semarthrit.2013.09.005
          24231065
          e6fe8746-7926-4460-9fde-d3217dc6d6bb
          © 2013 Published by Elsevier Inc.
          History

          Interstitial lung disease,Leflunomide,Methotrexate,Pneumonitis,Pulmonary fibrosis,Rheumatoid arthritis,Rituximab,TNF inhibitors,Tocilizumab

          Comments

          Comment on this article